Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Alexion Pharmaceutical Inc. buy ValueFreak

Start price
€81.44
31.03.20
Target price
€95.00
Performance (%)
10.793%
End price
€90.23
08.04.20

According to ValueFreak what are the pros and cons of Alexion Pharmaceutical Inc. for the foreseeable future?

Pros
Very capable Management
Very good company culture
Leading role in innovation
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Good rating
Very positive Cash Flow expected
High Investments for future growth
Strong uniques
Differentiated customer and product portfolio
Growths much faster than the competition
Sustainability is very important
Stable Large shareholder and/or long term investor
Medium risks for its business
Top 10 in its market
Very small cyclical dependencies
Known brand
Very Future proof/growth oriented business model
Cons
Low dividend yield expected

Comments by ValueFreak for this prediction

In the thread Alexion Pharmaceutical Inc. diskutieren

Published 31.03.20
Prediction Buy
Perf. (%) 10.793%
Target price 95.000
Change

Finanziell sehr solide aufgestellt - habe heute gekauft.,
https://ir.alexion.com/static-files/c1e8aa68-bbb7-4745-9a73-6efce71e29be

In the thread Trading Alexion Pharmaceutical Inc.

Published 08.04.20
Prediction Buy
Perf. (%) 10.793%
Target price 95.000
Change

Buy beendet

Current prediction by ValueFreak for Alexion Pharmaceutical Inc.

Alexion Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€89.92
€125.00
6.717%

Very capable Management
Very good company culture
Leading role in innovation
Could be very worthwhile Investment >20% year